ZEBRA is an Epstein-Barr virus (EBV) transcriptional activator that mediates a genetic switch between the latent and lytic states of the virus by binding to the promoters of genes involved in lytic DNA replication and activating their transcription. A computer survey revealed that 9 of 23 potential or known ZEBRA-responsive EBV genes contained two or more upstream binding sites; this suggested that ZEBRA can stimulate transcription synergistically. By using a series of synthetic promoters bearing one, two, three, five, and seven upstream recognition sites, we showed that ZEBRA activates transcription synergistically when templates bearing multiple sites were compared with a template bearing a single site. This phenomenon was observed in both uninfected and EBV-infected B-lymphoid cells and in vitro in a HeLa cell nuclear extract. DNase I footprinting was used to show that the synergy was not due to cooperative DNA binding mediated by direct contact between ZEBRA dimers. The in vitro experiments revealed two manifestations of synergy. One was seen when the levels of transcription observed with the same amounts of ZEBRA added to templates bearing different numbers of sites were compared. The other was observed when the two lowest concentrations of ZEBRA that stimulated measurable transcription from any given template were compared. On the basis of both the number of sites and the calculated Kd of ZEBRA for a single site, we estimated that the critical concentration of ZEBRA needed to elicit transcriptional synergy corresponds to a site occupancy of two or three bound ZEBRA dimers. Our results have biologic implications for both the EBV lytic cycle and other processes in which the concentration of an activator changes either temporally or spatially.
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Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis, manifests two distinct life styles: productive or lytic infection and nonproductive or latent infection (reviewed in references 36 and 37) . A predominantly lytic life cycle is characteristic of cells of the oropharynx, salivary glands, and tongue; infection of B lymphocytes is largely latent. Both lytic infection in the oropharynx and latent infection of B cells occur in patients with infectious mononucleosis. During lytic infection, the virus expresses approximately 100 genes encoded by its 172-kb genome. In latency, although genes unique to the lytic cycle are transcriptionally silent, up to 11 latent viral genes may be expressed; these encode six nuclear antigens, three latent membrane proteins, and two small RNAs (reviewed in reference 26). Epstein-Barr nuclear antigen 1 appears to be the only latent product which is indispensable; its interaction with the latent replication origin, oriP, maintains the viral episome (reviewed in reference 47). The spectrum of latent gene expression differs among several EBV-associated cancers, including Burkitt's lymphoma and nasopharyngeal carcinoma. Some diseases, such as oral hairy leukoplakia, appear to be exclusively the result of lytic replication (18) . In certain EBV-associated lymphoproliferative diseases and in nasopharyngeal carcinoma, the virus switches from a latent to a lytic life cycle (24) .
The switch from latency to lytic replication has been studied in EBV-transformed cultured B-lymphoid cell lines.
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Extracellular stimuli, including phorbol esters, butyrate, calcium ionophores, and anti-immunoglobulin, induce the latent virus to re-enter the lytic cycle (reviewed in reference 36) . Certain viral variants which have incurred spontaneous DNA rearrangements also leave latency (9, 42) . All extracellular stimuli and DNA rearrangements which induce the lytic cycle cause expression of the BZLF-1 gene of EBV. Transfection and expression of the BZLF-1 gene or its cDNA into B cells bearing latent virus is all that is needed to elicit a lytic response (9, 42, 43, 48) . On the basis of these biologic traits, the protein product of BZLF-1 was christened ZEBRA (BamHI Z fragment, Epstein-Barr replication activator [19] ).
ZEBRA is a site-specific transcription factor bearing a DNA recognition region homologous to that of Fos and Jun (15) and a coiled-coil dimerization motif (5, 16) . It binds as a dimer to specific DNA sites upstream of its responsive genes in DNase I footprinting and gel mobility shift experiments (5, 17, 28, 30) and activates transcription of target genes in cell culture transfection assays (6, 8, 17, 25, 29) . On the basis of these findings, it was concluded that ZEBRA mediates the genetic switch between the latent and lytic states of EBV by binding upstream of the genes required for viral replication and stimulating their transcription. The role of ZEBRA in viral synthesis is analogous to that played by MyoD in differentiation of muscle cells (12, 38) (3, 32) . Thus, the synergy could not be a result of cooperative DNA binding. Furthermore, the promiscuous heterosynergy exhibited between GALA and the glucocorticoid receptor (23) and between diverse combinations of eucaryotic activators (31, 32, 44, 45) is inconsistent with a model whereby cooperative binding to DNA is the major determinant of the synergy observed in gene activation.
We therefore asked whether ZEBRA stimulates transcription synergistically and, if so, whether it is due to cooperative DNA binding. By comparing ZEBRA-mediated transcriptional activation from templates bearing multiple sites with that from a template bearing a single site, we found that the effect of ZEBRA on transcription was synergistic, both in vivo and in vitro. As with some GAL4 derivatives (3), the synergy was not due to cooperative binding to DNA. Our in vitro experiments allowed us to distinguish a novel manifestation of synergy in which, on any given template, the transcriptional response to increasing ZEBRA concentrations was synergistic. Furthermore, templates bearing more sites were turned on at lower activator concentrations than templates bearing fewer sites. On the basis of our estimate of the Kd of ZEBRA for a single site, we calculated that the synergistic transition between trace and high levels of transcription occurred once two or three dimers of ZEBRA were bound to the test promoter. These data support models whereby a critical number of activators must bind to the template to elicit efficient transcriptional stimulation. The results have implications for induction of the viral lytic cycle, as well as other processes in which the concentration of an activator changes in a temporal or spatial fashion.
MATERIALS AND METHODS
Cloning, overexpression, and purification of ZEBRA. We constructed oligonucleotide primers flanking the ZEBRA cDNA; an NcoI site was placed immediately upstream and an XbaI site was placed downstream to the coding sequence. We then used the polymerase chain reaction to synthesize fragments of the intervening DNA. The fragments were initially cloned into Gem 3 and subsequently into tac expression vector pRW76 (52) .
A 12-liter volume of Escherichia coli (XA90) bearing the ZEBRA overexpressor plasmid was grown at 37°C to anA6. of 0.7, and isopropyl-p-D-thiogalactopyranoside (IPTG) was added to 1 mM. After 3 h, the cells were harvested, washed in a mixture containing 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid), pH 7.9, and 200 mM NaCl. The cell pellet was suspended in 250 ml of buffer A (20 mM HEPES [pH 7.9], 10 mM 2-mercaptoethanol, 1 mM EDTA, 1 mM phenylmethylsulfonyl fluoride, 10,ug each of leupeptin and pepstatin per ml) containing 0.6 M NaCl. The cells were lysed by sonication, and insoluble debris was removed by centrifugation at 10,000 x g for 10 min (-50% of the ZEBRA was soluble). Streptomycin sulfate was added to a final concentration of 2%, and after 10 min of gentle stirring the insoluble material was removed by centrifugation for 10 min at 10,000 x g. Ammonium sulfate was added to a final concentration of 26% to the supernatant, and after 30 min at 0°C, the precipitate was collected by centrifugation at 10,000
x g for 10 min. The pellet was suspended in buffer A to a conductivity equal to that of buffer A-0.2 M NaCl and loaded onto a 10-ml heparin Sepharose column pre-equilibrated in the same buffer. The column was washed with 30 ml of buffer A-0.2 M NaCl and developed with a linear gradient of buffer A containing 0.2 to 1 M NaCl. ZEBRA eluted with a broad peak centered at 0.6 M NaCl. The purest peak fractions were pooled; the protein was 90% pure as judged by Coomassie blue staining of sodium dodecyl sulfate (SDS)-polyacrylamide gels.
Construction of artificial reporter templates. Synthetic oligonucleotides encompassing the ZIIIB binding site (50) (21), all ZEBRA recognition sites were generated by computer search of the published EBV sequence. For BMLF-1, the distal ZRE determined by computer search was added to the known sites (2, 15, 25) . For BZLF-1, the distal ZIIIA site and the octamer sites were determined by computer search and added to previously published sites (17) . The data on Ds L sites are from references 8, 29, and 30. For Ds R sites, the ZRE and ZIIIA sites identified by computer search were added to previously identified sites (6, 7) . The ZEBRA protein is known to bind to several different classes of ZEBRA recognition sites distinguished by their DNA sequences; these are ZRE1, ZRE2, ZRE3, ZRE5, ZIIIA, ZIIIB, and AP-1 sites (see reference 50 for a discussion of relative affinities). reactions were terminated and the products were analyzed by primer extension by using a primer whose 5' end was positioned approximately 90 nucleotides downstream from the heterogeneous E4 transcription start sites. The extension products were fractionated on 18-cm-long, 1.5-mm-thick 10% polyacrylamide-urea gels. The gels were autoradiographed by exposure to Kodak XAR-5 film; the autoradiographs were scanned with an Zeineh densitometer by using dilutions of one of the primer extension products to generate a standard curve to quantitate the synergy at peak concentrations of ZEBRA. Alternately, the autoradiograph was scanned with a Joyce-Loebl densitometer to quantitate the transcription and synergy at suboptimal concentrations of ZEBRA. The data were normalized by using points that fell within the linear range of both sets of data.
Determination (31) . We chose to construct our promoters by using oligomers of the ZIIIB site from the BZLF-1 promoter (TTAGCAA). This site is a high-affinity ZEBRA recognition element (50) that is known to mediate ZEBRAstimulated transcription in vivo (17) . DNase I footprinting of recombinant ZEBRA on the synthetic promoters showed that the protein was capable of occupying each site greater than 90% of the time (data not shown). This demonstrates that the templates are suitable substrates for studying the transcriptional effects of ZEBRA bound to adjacent sites in vivo and in vitro.
In the in vitro experiments, DNA templates bearing one or more upstream ZEBRA binding sites were incubated in a HeLa nuclear extract with ZEBRA synthesized in and purified from E. coli; transcription was measured by primer extension of the reaction products. In the in vivo experiments, the same promoters, fused to the chloramphenicol acetyltransferase (CAT) gene, were cotransfected into uninfected and EBV-infected B cells with a plasmid that constitutively expresses ZEBRA from the cytomegalovirus CMV early enhancer and promoter (11) ; CAT activity was taken as a measure of transcription. Figure 2 is a Western blot in which we compared ZEBRA synthesized in and purified from E. coli with that synthesized in EBV-infected B95-8 marmoset cells induced with tetradecanoyl phorbol acetate to produce virus (27 This is probably an underestimate, as viruses in only 10 to 50% of B95-8 cells enter the lytic cycle after addition of an inducing agent.
Transactivation by ZEBRA in uninfected and infected B lymphocytes. The templates used in our study are shown schematically in Fig. 3A . Electroporation was used to cotransfect reporter templates containing zero, one, two, and three sites with an effector plasmid, bearing ZEBRA under control of the CMV enhancer, into HR-1 clone 16 cells (Fig. 3B) . HR-1 clone 16 cells are cultured B lymphocytes which maintain EBV in a latent but inducible state (49) . The amount of effector plasmid was titrated on the two-site template to obtain the maximal amount of transcriptional stimulation; these amounts were used in all subsequent experiments. We found that ZEBRA activated transcription 8.9-fold from a single site, while the stimulation on two sites was 118-fold. The effect was synergistic, as the signal elicited on the three-site template was seven times greater than the signal expected if ZEBRA had only an additive effect on transcription with respect to the single-site template. We conclude that ZEBRA stimulates transcription synergistically in vivo. The first measurable synergy occurred when templates bearing one site were compared with templates containing either two or three sites.
To determine whether other EBV-encoded gene products are required for synergy mediated by ZEBRA, a similar cotransfection experiment utilizing electroporation was performed with EBV-negative B-lymphocyte cell line BJAB (Fig. 3C) . Trace stimulation by ZEBRA was observed on a template bearing a single site, whereas CAT activity on a two-site template was stimulated 42.5-fold. The experiment was repeated with nearly identical results (data not shown). When the data for the two experiments were averaged, there was 18.1-fold synergy when comparing two sites with one site and 7.5-fold synergy when comparing three sites with one site, as illustrated by the bar graph in Fig. 3D . Thus, ZEBRA is able to stimulate transcription synergistically in the absence of EBV gene products. In agreement with this conclusion, we also observed transcriptional activation and synergy by ZEBRA on the model reporter templates in several EBV-negative mammalian cell lines (data not shown). This suggests that ZEBRA interacts with a ubiquitous component(s) of the mammalian transcription machinery.
ZEBRA does not bind cooperatively to its DNA sites. One plausible explanation for the transcriptional synergy observed when comparing templates bearing different numbers of sites is that ZEBRA, like the A repressor, binds cooperatively to adjacent sites on DNA. Previous studies have shown that when procaryotic and eucaryotic activators bind DNA cooperatively, the effect is readily detectable by using a DNase I footprinting assay (21, 53) . We therefore employed this technique to measure the affinities of recombinant ZEBRA for templates bearing one and three sites.
If the transcriptional synergy is simply a reflection of cooperative binding by ZEBRA, then we would expect, on the basis of the results shown in Fig. 3 , that the activator would have a significantly higher affinity for the three-site template than for a template containing a single site. Figure  4 shows that, at the same DNA concentration used in the transcription reactions, both templates became saturated (75 to 90%) with nearly identical amounts of ZEBRA (208 ng). transcription will be observed at lower activator concentrations on those templates. However, Fig. 5 shows that the peak transcriptional levels in vitro occurred at the same concentration on templates bearing three, five, and seven sites. We conclude that ZEBRA does not bind cooperatively to our reporter templates. Flemington and Speck reached a similar conclusion by examining the affinity of ZEBRA for * * adjacent sites within BZLF-1 (17 -, r.
. less than that of the protein, 30 nM is a reasonable estimate for the Kd, assuming that most of the protein is capable of binding DNA.
Biochemical evidence for two manifestations of transcriptional synergy. The ability of ZEBRA to stimulate transcription was measured in the well-characterized HeLa cell nuclear extract system (13) . Templates bearing one, three, five, and seven sites were incubated in the extracts with increasing amounts of recombinant ZEBRA. The results shown in Fig. 5 revealed four interesting features of ZEBRAmediated gene activation. (i) Transcription increased dramatically with the number of sites (Fig. SA) ; this is the classical manifestation of synergy between sites. We observed no measurable transcription on a template bearing a single site, an intermediate level on a three-site template, and a high level on a five-site template. The peak signal on a template bearing five sites was nearly identical to that seen on the seven-site template. We interpret this to mean that some component in the HeLa extract becomes limiting and thus transcription becomes saturated. To quantitate the transcription, the products obtained on the seven-site template with 208 ng of ZEBRA were serially diluted until no signal was detectable on the autoradiograph. The other reaction products were scanned with a densitometer and compared with the points on this curve. When this method was used, with 208 ng of protein, there was 9-fold synergy when comparing three sites with one site and 16-fold synergy when comparing five sites with one site (Fig. SB) . With 208 ng of ZEBRA, there was little synergy between three and seven sites. In contrast, at lower concentrations of protein there was still synergy when comparing the three-site template with the five-and sevensite templates; this was quantitated by laser densitometer tracings by using the values obtained from 69 ng of protein.
We found 4.8-fold synergy when comparing five with three sites and 3.6-fold synergy when comparing seven sites with three sites (Fig. SC) . Thus, we were able to recreate synergy by ZEBRA in vitro efficiently at both high and low activator concentrations.
(ii) The amount of ZEBRA that stimulated detectable transcription decreased with increasing numbers of sites. With densitometry, the same trace signal was evident with 69 ng of ZEBRA on the three-site template, 23 ng on the five-site template, and 8 ng on the seven-site template. Thus, templates bearing more sites are turned on at lower ZEBRA concentrations.
(iii) On any given template, the transcriptional response to increasing ZEBRA concentrations, going from the lowest dose which stimulated transcription to the next highest dose, was synergistic (Fig. 5D) (iv) The last point is that transcription on each of the multisite templates increased with the concentration of ZEBRA, reached a plateau, and then unexpectedly dipped (Fig. SA) (22) . However, in eucaryotes synergy can be observed in the absence of cooperative binding to DNA (3, 32, 39) . Particularly important is the finding that synergy can occur under conditions of activator excess (3, 32) with two or three. In BJAB cells and in the HeLa extract, there was seven-to ninefold synergy when the signal from two or three sites was compared with that from one site. However, synergy was also observed in vitro, albeit to a lesser degree, when stimulation on the five-and seven-site templates was compared with that on the three-site reporter. The synergy was particularly evident at subsaturating concentrations of ZEBRA. The results of DNase I footprinting experiments suggest that the synergy cannot be attributed mainly to cooperative DNA binding, although we cannot exclude the possibility of a minor contribution.
To explain this form of synergy, the models shown in Fig.  6 have been invoked (3, 32, 39, 41) . In model I, multiple molecules of ZEBRA simultaneously contact a single target protein in the transcriptional machinery (3, 4) or two (identical or different) molecules which themselves interact (reviewed in reference 4). In model II, once a critical number of activator molecules have bound to the promoter, the target would overcome a kinetic threshold needed to effect transcription. For example, the activator might have to contact its target for a certain amount of time for the next step in the initiation process to occur. Increasing the number of activators would increase the probability and thus the time of interaction between activator and target. In the latter model, ZEBRA TRANSCRIPTIONAL SYNERGY 4811 the subsequent binding of other components of the transcription apparatus must be exponential to translate the linear change in probability into a synergistic increase in transcription. Nevertheless, in both models the effect of the two activators bound at adjacent sites is to induce cooperative binding of elements of the transcription apparatus; either the direct target or components that bind subsequently. We also note that the interaction energy, rather than directly affecting the affinity of the target, could be funneled into qualitative alterations in the transcription complex, such as allosteric changes. The prediction of this class of models is that, as we showed, synergism should be observed as a function of protein concentration; once a critical number of ZEBRA molecules are bound to promoter DNA, they turn on the gene to a high level.
Synergy and EBV gene regulation. We hypothesize that synergy is important for efficient transcriptional stimulation by ZEBRA in vivo. In evaluating the role of synergy, we imagine at least four interrelated parameters which could be varied to control the levels of both lytic gene transcription and temporal expression. These variables are (i) the level of active ZEBRA protein, (ii) the number of ZEBRA binding sites, (iii) the affinity of ZEBRA for the upstream sites, and (iv) the presence of binding sites for other viral or cellular factors which affect transcription. We discuss below the possible role of these parameters in the EBV lytic cycle.
(i) Our studies show that model promoters containing the highest number of sites are activated at the lowest ZEBRA protein concentration. Our hypothesis is that binding of two or three ZEBRA dimers to a promoter turns on the gene to a high level. Simply on the basis of increased probability of binding, a template that contains more than three sites requires a lower concentration of ZEBRA to achieve binding of two or three activators. This could, in principle, provide a mechanism for temporal control of lytic cycle gene expression. Genes containing the greatest number of high-affinity sites would be activated earlier, and genes containing fewer sites would be activated later as the concentration of ZEBRA rises during induction.
Close examination of the kinetics of expression of ZEBRA in clone 16 cells suggests that there are two phases of ZEBRA expression (49): low-level expression of the protein between 3 and 12 h after induction and a sustained higher level after 18 h. Thus, ZEBRA protein concentration might need to rise to a critical level, at which it would bind its promoter and become autostimulatory (the BZLF-1 promoter contains three upstream ZEBRA binding sites [ Fig. 1] [17]).
(ii) As illustrated in Fig. 1 , many ZEBRA-responsive promoters contain multiple sites to which ZEBRA may bind. In addition to specific ZEBRA response elements, ZEBRA may also bind and activate from AP-1 sites (15) which are found in at least two promoters (BMRF-1 and BMLF-1) which contain recognizable ZEBRA binding sites. Our studies predict that at saturating activator concentrations, there will be a correlation between overall transcription levels and the number of upstream sites to which ZEBRA can bind. Promoters containing the most ZEBRA binding sites will be the most active. This might reflect the need for a greater amount of a particular gene product. For example, lytic DNA replication might require greater amounts of a singlestranded DNA-binding protein than of DNA polymerase.
(iii) An additional level of gene control could be achieved by varying the affinity of ZEBRA for its sites. For example, during induction of the lytic cycle the virus could control temporal expression of two genes whose promoters contain the same number of sites which, however, differ in affinity. The promoter bearing the high-affinity sites would be activated earlier at lower concentrations of ZEBRA, whereas the promoter bearing the weaker sites would turn on later. Yet, at concentrations of ZEBRA sufficient to saturate both promoters, the two genes could be transcribed at identical levels.
(iv) There are some promoters identifiable by computer search which contain a single ZEBRA binding site. None of these promoters has been shown to be directly transactivated by ZEBRA in vivo. Promoters containing only a single ZRE may have been designed so that the downstream genes can be activated by ZEBRA in concert with another viral or cellular activator, such as the EBV-encoded Rta transactivator (8, 10, 35) or the cellular AP-1 protein, a process called heterosynergy. There may also exist promoters containing ZEBRA sites and sites for unidentified viral and cellular activators that may also be activated through heterosynergy.
Synergy between ZEBRA and cellular factors may reflect the need for a gene product only under certain conditions when the cellular factor is present or active. Synergy with other viral transactivators may reflect the transition from an early to an intermediate stage or control of a functionally related group of genes. We note, however, that for EBV to maintain the latent state and to ensure that ZEBRA expression is the principal regulator of the lytic switch, the BZLF-1 gene must be kept under tight control. Furthermore, lytic cycle genes must have restricted access to cellular factors that could turn on the lytic cycle in the absence of ZEBRA. Therefore, it seems reasonable that many EBV promoters were designed to respond solely to ZEBRA, with little help from cellular activators. However, a systematic analysis of ZEBRA-responsive promoters in vitro and in vivo is needed to determine whether the principles described in this report apply to the EBV genetic switch.
